◆ 会议时间：2024年11月6日至10日
◆ 会议地点：美国 休斯顿
◆ 会议简介：
2024年第39届癌症免疫治疗学会(SITC)年会将于2024年11月6日至10日在美国休斯顿举行。SITC年会是世界上最大的专注于癌症免疫治疗的国际盛会，每年的会议和会前教育计划都会吸引超过3500名来自学术界、监管部门和政府机构宣的国际行业领袖与代表。SITC为与会者提供了一个多学科的教育和互动平台，共同推动科学进步，发现突破性的进展，力求改善所有癌症患者的预后（未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网）。
癌症免疫治疗学会(SITC)成立于1984年，是世界领先的专业致力于通过推进癌症免疫治疗科学与应用来改善癌症患者预后的非营利组织，SITC为来自世界各地的科学家、学者、研究人员、临床医生、政府代表和行业领导者提供服务。目前，SITC拥有超过1700名成员，代表17种医疗专业，从事至少十几种癌症的研究和治疗。SITC的愿景是通过促进科学交流与合作教育计划，旨在让癌症患者被“治愈”在某一天能够成为现实。
The SITC Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides international leaders from academia, regulatory and government agencies, as well as industry representatives with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients.
The Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting & Pre-Conference Programs (SITC 2024)
Date: Nov 6 - 10, 2024
Venue: George R. Brown Convention Center，Houston，USA
SITC 2024 摘要征文投稿：
Regular, Young Investigator Award (YIA), and Immune Engineering Abstract Dates
April 24, 2024
Regular Abstract, YIA Abstract, and Immune Engineering Abstract Submission Site Opens
June 27, 2024
Regular Abstract, YIA Abstract, and Immune Engineering Abstract Submission Site Closes at 5 p.m. PDT
Aug. 2, 2024
Regular Abstract, YIA Abstract, and Immune Engineering Abstract Notifications Sent
Aug. 9, 2024
Regular Abstract, YIA Abstract, and Immune Engineering Abstract Presentation Acceptance Confirmations & Deadline for Regular, YIA, and Immune Engineering Abstract Withdrawals (Withdrawals must be made by emailing education@sitcancer.org to indicate a withdrawal)
Oct. 4, 2024
Regular, YIA, and Immune Engineering Abstract Title & Author Information Released at 9 a.m. EDT
Nov. 5, 2024
Embargo Lifted & Full Regular, YIA, and Immune Engineering Abstracts Made Public at 8 a.m. CST/9 a.m. EST. All accepted abstracts are available in the JITC Supplement
Nov. 6–10, 2024
39th Annual Meeting & Pre-Conference Programs
Feb. 2025
Final Supplement Published in JITC
点此提交摘要>>>Submit Abstract>>>
Late-Breaking Abstracts - Clinical Only (LBA) Dates
July 15, 2024
LBA Submission Site Opens
Sept. 12, 2024
LBA Submission Site Closes at 5 p.m. PDT
Sept. 25, 2024
LBA Notifications Sent
Sept. 30, 2024
LBA Presentation Acceptance Confirmation Due & Deadline for LBA Withdrawals (Withdrawals must be made by emailing education@sitcancer.org to indicate a withdrawal)
Oct. 30, 2024
LBA Title & Author Information Released at 9 a.m. EDT
Nov. 5, 2024
Embargo Lifted & LBA Made Public at 8 a.m. CST/9 a.m. EST. All accepted abstracts are available in the JITC Supplement
Nov. 6–10, 2024
39th Annual Meeting & Pre-Conference Programs
Feb. 2025
Final Supplement Published in JITC
Abstract Types
New for SITC 2024 - Call for Immune Engineering Abstracts
This year the Pre-Conference Program, Immune Engineering Workshop, on Thursday, Nov. 7, from 9 a.m.–5 p.m., will offer additional opportunities for poster and oral presentations. Abstracts that focus on immune engineering and related topics will be eligible for this opportunity. Abstract submitters will be able to select if they would like their abstract considered for the Immune Engineering Workshop within the Regular and YIA Submission Portal.
The time frame to submit your latest research in the cancer immunotherapy field to the 39th Annual Meeting for consideration as an oral abstract presentation and/or poster abstract presentation is April 24, 2024 until 5 p.m. PDT on June 27, 2024.
Young Investigator Award (YIA) Abstracts
Regular Abstracts with primary and presenting authors that are students, postdoctoral research fellows, clinical fellows, or junior faculty with three or fewer years on staff and are current SITC members, may be eligible to receive a Young Investigator Award (YIA). Five YIAs will be reserved for those who self-identify as individuals from underrepresented racial and ethnic groups in the Biomedical Sciences according to the NIH definition. YIA Abstracts require a letter of recommendation as well as additional information regarding the percentage of contribution by the primary and presenting author. The time frame to submit a YIA Abstract to the 39th Annual Meeting is April 24, 2024 until 5 p.m. PDT on June 27, 2024.
Those selected for the Presidential Travel Award will be invited to give an oral abstract presentation during the Presidential Session from 1:30–2:55 p.m. on Saturday, Nov. 9, 2024 (session time subject to change). An abstract submitted for a YIA that does not receive an award may still be accepted as an abstract for SITC 2024 and will be considered a Regular Abstract.
For more information about the YIAs as well as the criteria and eligibility, please click here.
Late-Breaking Abstracts - Clinical Only (LBA)
Late-breaking Abstract - Clinical Only (LBA) submission is solely for abstracts with late-breaking data from interventional clinical trials in humans and not for abstracts submitted “late”. The LBA deadline is not intended to be an extension of the general submission deadline. LBAs highlight novel and practice-changing in-human clinical studies and only apply to data that would have not otherwise have been presented as an abstract at the 39th Annual Meeting.
Authors of LBAs do not need to submit an application or a place-holder abstract. LBAs should be submitted during the LBA submission period, from July 15–Sept. 12 at 5 p.m. PDT.
If a LBA is not accepted, it will not be published or presented at the meeting. There is no longer an option for it to be considered as a Regular/YIA Abstract.
LBAs are considered for a limited allocation of oral and poster presentation slots on either Friday, Nov. 8 or Saturday, Nov. 9.
注册费：
Annual Meeting (Fri., Sat., Sun.)
ROOM: Various
|
Early Registration FeeEnds at 11:59 p.m. PT on Aug. 14 |
Regular Registration FeeStarts at 12:00 a.m. PT on Aug. 15 |
Onsite Registration FeeStarts at 12:00 a.m. PT on Nov. 1 |
| MembersAcademic/Clinic/Non-Industry/ Non-Industry Pharmacist |
$815 |
$1,015 |
$1,065 |
| MemberGovernment |
$550 |
$750 |
$800 |
| MembersStudent/Non Industry Nurse/Patient Advocate |
$100 |
$300 |
$350 |
| MembersFoundation/Non-Profit/Patient Advocacy Organization |
$100 |
$300 |
$350 |
| MembersIndustry - Includes Industry Nurse and Industry Pharmacist |
$1,705 |
$1,905 |
$1,955 |
| MembersConsultant/Small Biotech [50 or less company employees] |
$1,080 |
$1,280 |
$1,330 |
| MemberPatient/Patient Caregiver |
$105 |
$105 |
$105 |
| Non-MembersPatient/Patient Caregiver |
$105 |
$105 |
$105 |
| Non-MembersAcademic/Clinic/Non-Industry/ Non-Industry Pharmacist |
$920 |
$1,120 |
$1,170 |
| Non-MembersGovernment |
$630 |
$860 |
$910 |
Non-MembersStudent/Nurse/Patient AdvocateTo obtain Non-Member Student rates, student must
provide documentation of student status. |
$380 |
$580 |
$630 |
| Non-MembersFoundation/Non-Profit/Patient Advocacy Organization |
$380 |
$580 |
$630 |
| Non-MembersIndustry Includes Industry Nurse and Industry Pharmacist |
$1,870 |
$2,070 |
$2,120 |
| Non-MembersSmall Biotech/Consultant [50 or less company employees] |
$1,285 |
$1,485 |
$1,535 |
| MembersLow- and Lower-Middle-Income Economies |
$0 |
$0 |
$0 |
| Non-MembersLow- and Lower-Middle-Income Economies |
$25 |
$25 |
$25 |
PRE-CONFERENCE PROGRAMS
Rates for each of the following Pre-Conference Programs:
- Primer on Tumor Immunology and Cancer
- Tumor Infiltrating Lymphocytes (TIL) Program
- Immune Engineering Workshop
- Beyond Checkpoint Inhibitors: New Immuno-oncology Modalities and Approaches
|
Early Registration FeeEnds at 11:59 p.m. PT on Aug. 14 |
Regular Registration FeeStarts at 12:00 a.m. PT on Aug. 15 |
Onsite Registration FeeStarts at 12:00 a.m. PT on Nov. 1 |
| MembersAcademic/Clinic/Non-Industry/ Non-Industry Pharmacist |
$340 |
$540 |
$590 |
| MemberGovernment |
$210 |
$420 |
$470 |
| MembersStudent/Non Industry Nurse/Patient Advocate |
$100 |
$300 |
$350 |
| MembersFoundation/Non-Profit/Patient Advocacy Organization |
$100 |
$300 |
$350 |
| MembersIndustry - Includes Industry Nurse and Industry Pharmacist |
$550 |
$750 |
$800 |
| MembersConsultant/Small Biotech [50 or less company employees] |
$375 |
$575 |
$640 |
| MemberPatient/Patient Caregiver |
$105 |
$105 |
$105 |
| Non-MembersPatient/Patient Caregiver |
$105 |
$105 |
$105 |
| Non-MembersAcademic/Clinic/Non-Industry/ Non-Industry Pharmacist |
$370 |
$570 |
$870 |
| Non-MembersGovernment |
$235 |
$425 |
$475 |
Non-MembersStudent/Nurse/Patient AdvocateTo obtain Non-Member Student rates, student must
provide documentation of student status. |
$345 |
$545 |
$595 |
| Non-MembersFoundation/Non-Profit/Patient Advocacy Organization |
$345 |
$665 |
$715 |
| Non-MembersIndustry Includes Industry Nurse and Industry Pharmacist |
$660 |
$860 |
$1,060 |
| Non-MembersSmall Biotech/Consultant [50 or less company employees] |
$440 |
$640 |
$690 |
| MembersLow- and Lower-Middle-Income Economies |
$0 |
$0 |
$0 |
| Non-MembersLow- and Lower-Middle-Income Economies |
$25 |
$25 |
$25 |
Grant Writing Workshop
ROOM: Level 2 – Houston Ballroom, Salon 2 – Marriott Marquis
|
Early Registration FeeEnds at 11:59 p.m. PT on Aug. 14 |
Regular Registration FeeStarts at 12:00 a.m. PT on Aug. 15 |
Onsite Registration FeeStarts at 12:00 a.m. PT on Nov. 1 |
General Attendee
|
$25 |
$25 |
$25 |
| MembersLow- and Lower-Middle-Income Countries |
$0 |
$0 |
$0 |
| Non-MembersLow- and Lower-Middle-Income Economies |
$10 |
$10 |
$10 |
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
